Difference between revisions of "Part:BBa K5443003"
(4 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
+ | 4-Hydroxyphenylacetate (HpaBC) 3-hydroxylase (C3H) from <i>E. coli</i> is an alternative enzyme variant to Sam5 to catalyse the hydroxylation of 4-coumaric acid to yield caffeic acid (Fig. 1). This functions as the second step in our vanillin biosynthesis pathway. HpaBC is a two-component flavin adenine dinucleotide (FAD)-dependent monooxygenase that has a broad host range, and acts on a wide range of phenolic compounds. In our vanillin biosynthesis pathway, HpaBC is performing an “unnatural” role in hydroxylating coumarate (p-coumaric acid), since its normal physiological substrate is 4-hydroxyphenylacetate. | ||
− | + | This part builds on the work of earlier iGEM teams, who contributed HpaBC Parts as follows: [https://parts.igem.org/Part:BBa_K1124011 BBa_K1124011], [https://parts.igem.org/Part:BBa_K4912001 BBa K4912001], and [https://parts.igem.org/Part:BBa_K4912008 BBa_K4912008]. | |
− | + | ||
− | + | ||
+ | <html> | ||
+ | <figure> | ||
+ | <img src=" https://static.igem.wiki/teams/5443/c3h-reaction.jpg" style="width:600px;height:auto"> | ||
+ | <figcaption> | ||
+ | <b>Figure 1. C3H-catalysed conversion of p-coumaric acid to caffeic acid.</b><br> | ||
+ | <i>This reaction represents the second step in our vanillin synthesis pathway. The C3H enzyme HpaBC converts coumarate (p-coumaric acid) into caffeic acid.</i> | ||
+ | </figcaption> | ||
+ | </figure> | ||
+ | </html> | ||
Latest revision as of 13:44, 2 October 2024
4-Hydroxyphenylacetate (HpaBC) 3-hydroxylase (C3H) from E. coli is an alternative enzyme variant to Sam5 to catalyse the hydroxylation of 4-coumaric acid to yield caffeic acid (Fig. 1). This functions as the second step in our vanillin biosynthesis pathway. HpaBC is a two-component flavin adenine dinucleotide (FAD)-dependent monooxygenase that has a broad host range, and acts on a wide range of phenolic compounds. In our vanillin biosynthesis pathway, HpaBC is performing an “unnatural” role in hydroxylating coumarate (p-coumaric acid), since its normal physiological substrate is 4-hydroxyphenylacetate.
This part builds on the work of earlier iGEM teams, who contributed HpaBC Parts as follows: BBa_K1124011, BBa K4912001, and BBa_K4912008.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]